Joincare Pharmaceutical Group Industry Co.,Ltd. (SHA:600380)
China · Delayed Price · Currency is CNY 11.27
+0.08 (0.71%)
Apr 8, 2026, 3:00 PM CST
SHA:600380 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 2,865 | 1,387 | 1,443 | 1,503 | 1,328 |
Depreciation & Amortization | 817.82 | 804.62 | 1,054 | 837.7 | 620.45 |
Other Amortization | 87.87 | 280.6 | 76.52 | 65.57 | 43.99 |
Loss (Gain) From Sale of Assets | -2.97 | -37.01 | 2.75 | 17.23 | -17.62 |
Asset Writedown & Restructuring Costs | 108.34 | 21.24 | 0.57 | 14.46 | 1.19 |
Loss (Gain) From Sale of Investments | -71.49 | -55.84 | -53.39 | 19.68 | -48.52 |
Provision & Write-off of Bad Debts | - | 4.38 | 17.09 | 2.98 | 9.19 |
Other Operating Activities | 190.47 | 1,761 | 1,812 | 1,543 | 1,446 |
Change in Accounts Receivable | -39.57 | 122.42 | 6,974 | 2,381 | -1,594 |
Change in Inventory | 357.42 | -51.29 | -415.39 | -604.73 | -306.33 |
Change in Accounts Payable | -282.14 | -493.78 | -7,047 | -1,925 | 1,037 |
Change in Other Net Operating Assets | - | -18.05 | 90.25 | 51.13 | 89.63 |
Operating Cash Flow | 3,892 | 3,636 | 3,929 | 3,978 | 2,563 |
Operating Cash Flow Growth | 7.03% | -7.45% | -1.23% | 55.19% | -15.27% |
Capital Expenditures | -767.2 | -979.13 | -1,130 | -1,148 | -1,521 |
Sale of Property, Plant & Equipment | 55.12 | 1.5 | 15.3 | 3.1 | 9.4 |
Cash Acquisitions | - | - | -22.46 | - | - |
Divestitures | - | -28.47 | - | - | 3.31 |
Investment in Securities | -1,332 | -169.38 | 130.21 | -1,230 | -580.79 |
Other Investing Activities | -1,824 | 21.47 | 129.67 | 122.15 | 125.34 |
Investing Cash Flow | -3,869 | -1,154 | -877.42 | -2,252 | -1,964 |
Long-Term Debt Issued | 4,182 | 6,637 | 4,274 | 5,340 | 3,535 |
Long-Term Debt Repaid | -5,273 | -7,309 | -3,831 | -3,752 | -2,621 |
Net Debt Issued (Repaid) | -1,092 | -672.08 | 442.75 | 1,588 | 913.44 |
Issuance of Common Stock | - | 96.56 | 38.12 | 701.08 | 82.58 |
Repurchase of Common Stock | - | -1,188 | -821.54 | -780.55 | -938.08 |
Common Dividends Paid | -447.07 | -468.15 | -480.86 | -389.04 | -382.47 |
Other Financing Activities | -1,408 | -804.11 | -1,106 | -553.15 | -650.36 |
Financing Cash Flow | -2,946 | -3,036 | -1,927 | 566.12 | -974.9 |
Foreign Exchange Rate Adjustments | -173.68 | 55.48 | 38.41 | 189.29 | -49.29 |
Net Cash Flow | -3,097 | -498.22 | 1,162 | 2,481 | -425.26 |
Free Cash Flow | 3,125 | 2,657 | 2,799 | 2,830 | 1,042 |
Free Cash Flow Growth | 17.59% | -5.06% | -1.10% | 171.67% | -52.53% |
Free Cash Flow Margin | 20.54% | 17.01% | 16.81% | 16.51% | 6.55% |
Free Cash Flow Per Share | 1.71 | 1.42 | 1.47 | 1.49 | 0.54 |
Cash Income Tax Paid | 1,670 | -116.68 | -54.22 | 103.82 | -0.08 |
Levered Free Cash Flow | 1,796 | 1,484 | 1,578 | 1,593 | 424.23 |
Unlevered Free Cash Flow | 1,796 | 1,561 | 1,670 | 1,680 | 480.65 |
Change in Working Capital | -103.23 | -529.32 | -423.56 | -25.24 | -820.13 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.